Wang Lilan, Ru Zixuan, Gao Shengnan, Lv Na, Li Kerou, Qiao Hong
Department of Endocrinology, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Front Endocrinol (Lausanne). 2025 Aug 27;16:1628670. doi: 10.3389/fendo.2025.1628670. eCollection 2025.
Investigate the thyroid function and thyroid autoantibodies in adult Graves' disease (GD) patients at different treatment stages and healthy adults with serum iodine concentration (SIC), and analyze the relationship between SIC and thyroid function as well as thyroid autoantibodies.
GD-induced hyperthyroid patients and healthy normal controls will be recruited from the Endocrinology Clinic. Peripheral venous blood samples will be collected, and the SIC content will be determined by the arsenic cerium catalytic spectrophotometry method. Thyroid function indicators will be detected by electrochemical immunoassay analysis, the Pearson/Spearman correlation analysis will be used to analyze the correlation between SIC and thyroid function indicators.
A total of 510 participants were included, of which 80 were healthy adults and 430 had GD. The SIC levels were 63.78 ± 18.92μg/L and 74.09 ± 29.85μg/L. There was a significant difference in SIC levels (100.15 ± 40.25μg/L vs 65.74 ± 19.37μg/L, P < 0.05). In terms of iodine deficiency degree (<45μg/L), there was no significant difference between the two groups (11.25% vs. 12.50%, P>0.05). Correlation analysis showed that SIC was positively correlated with FT4 and TRAb (r=0.213, r=0.369, P<0.05). In newly diagnosed GD patients, the TPOAb concentration and positivity rate in the low blood iodine group were higher than those in the high blood iodine and appropriate blood iodine groups (P<0.05). The TgAb level in the high blood iodine group was greater than that in the low blood iodine and appropriate blood iodine groups (P<0.05), while the TgAb positivity rate in the low blood iodine group was higher than that in the high blood iodine and appropriate blood iodine groups, although there was no significant difference (P>0.05).
1.The SIC levels in GD patients are higher than those in the healthy control group, and the SIC levels in untreated GD patients are higher than those in treated GD patients.2.There is a potential association between SIC and thyroid function indicators. In newly diagnosed GD patients, SIC shows a positive correlation trend with FT4 and TRAb.3.There are differences in the distribution of patient groups with different iodine contents in the blood, and there are also differences in the levels and positivity rates of TPOAb and TgAb.
研究不同治疗阶段的成年格雷夫斯病(GD)患者及健康成年人的甲状腺功能、甲状腺自身抗体与血清碘浓度(SIC),并分析SIC与甲状腺功能及甲状腺自身抗体之间的关系。
从内分泌门诊招募GD所致甲亢患者及健康正常对照。采集外周静脉血样本,采用砷铈催化分光光度法测定SIC含量。采用电化学免疫分析检测甲状腺功能指标,用Pearson/Spearman相关分析分析SIC与甲状腺功能指标之间的相关性。
共纳入510名参与者,其中80名健康成年人,430名患有GD。SIC水平分别为63.78±18.92μg/L和74.09±29.85μg/L。SIC水平存在显著差异(100.15±40.25μg/L对65.74±19.37μg/L,P<0.05)。在碘缺乏程度(<45μg/L)方面,两组之间无显著差异(11.25%对12.50%,P>0.05)。相关分析显示,SIC与FT4和TRAb呈正相关(r=0.213,r=0.369,P<0.05)。在新诊断的GD患者中,低血碘组的TPOAb浓度和阳性率高于高血碘组和适血碘组(P<0.05)。高血碘组的TgAb水平高于低血碘组和适血碘组(P<0.05),而低血碘组的TgAb阳性率高于高血碘组和适血碘组,尽管差异无统计学意义(P>0.05)。
1.GD患者的SIC水平高于健康对照组,未治疗的GD患者的SIC水平高于已治疗的GD患者。2.SIC与甲状腺功能指标之间存在潜在关联。在新诊断的GD患者中,SIC与FT4和TRAb呈正相关趋势。3.不同血碘含量患者组的分布存在差异,TPOAb和TgAb的水平及阳性率也存在差异。